Clinical significance of HLA antigens and non-HLA antigens in solid organ transplantation

Current Opinion in Organ Transplantation

Volumn 11, Issue 4, 2006, Pages 418-424

  Kerman, Ronald H ^a   Stepkowski, Stanislaw M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Endothelial antigens; HLA antigens; MICA; Non HLA antigens; Vimentin

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; CELLULAR IMMUNITY; CHRONIC ALLOGRAFT NEPHROPATHY; CORRELATION ANALYSIS; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA MATCHING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NONHUMAN; ORGAN TRANSPLANTATION; REVIEW; TREATMENT OUTCOME;

EID: 33746354580     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000236707.06200.17     Document Type: Review

References (60)

1. Opelz G, Mickey MR, Terasaki PI. Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc 1977; 9:27-30.
2. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3:665-673.
3. Su X, Zanios SA, Chakkera H, et al. Dimishing significance of HLA matching in kidney transplantation. Am J Transplant 2004; 4:1501-1508.
4. Terasaki PI. Deduction of the fraction of immunologic and nonimmunologic failure in cadaveric donor transplants. In: Cecka JM, Terasaki PI, editors. Clinical transplants 2003. Los Angeles: UCLA Immunogenetics Center; 2003 . pp. 449-452.
5. Paul LC, Van Es LA, Van Rood JJ, et al. Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejected renal allografts. Transplantation 1979; 27:175-179.
6. Cerilli J, Brasile L, Galouzis T, DeFrancis ME. Clinical significance of anti-monocyte antibody in kidney transplant recipients. Transplantation 1981; 32:495-497.
7. Moraes JR, Stastny P. A new antigen system expressed in human endothelial cells. J Clin Invest 1977; 60:449-454.
8. Moraes JR, Stastny P. Human endothelial cell antigens: molecular independence from HLA and expression in blood monocytes. Transplant Proc 1977; 9:605-607.
9. Sumitran-Karuppan S, Tyden G, Reinholt F, et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transplant Immunol 1997; 5:321-327.
10. Zwirner NW, Marcos CY, Mirabaha, et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Human Immunol 2000; 61:917-924.
11. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71:886-892.
12. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365:1570-1576. This outlines the benefit of cytotoxic PRA screening to identify non-HLA antibodies.
13. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1 receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352:558-569.
14. Flye MW. Immunohematology. In: Flye MW, editor. Principles of organ transplantation. Philadelphia: WB Saunders; 1989. pp. 236-252.
15. Klein J, editor. Natural history of the major histocompatibility complex. New York: John Wiley; 1987.
16. Gorer A, Lyman S, Snell GD. Studies on the genetic and antigenic basis of tumor transplantation Linkage between a histocompatibility gene in mice. Proc R Soc Londn 1948; 135:499-505.
17. Medawar PB. Immunity to homologous grafted skin: The relationship between antigens of the blood and skin. Brit J Exper Path 1946; 27:15-27.
18. Dausset J. Leucoagglutinins and blood transfusions. Vox Sang 1954; 4:190-198.
19. Payne R, Rolfs MR. Fetal-maternal leucocyte incompatibility. J Clin Invest 1958; 37:1756-1763.
20. Van Rood JJ, Van Leeuen A, Eerniss JG. Leucocyte antibodies in sera of pregnant women. Nature 1963; 181:1735-1736.
21. Van Rood JJ, Van Leeuen A. Leucocyte grouping: a method and its application. J Clin Invest 1963; 42:1382-1387.
22. Takemoto S, Port FK, Claas FHJ, Duquesnoy RJ. HLA matching for kidney transplantation. Human Immunol 2004; 65:1489-1505.
23. Cecka JM. The changing role of HLA matching. In: Terasaki PI, editor. Clinical Transplants 1986. Los Angeles: UCLA Tissue Typing Lab; 1987pp. 141-155.
24. Kerman RH. The major histocompatibility complex in human transplantation. In: Tejani A, Fine R, editors. Pediatric Renal Transplantation. New York: John Wiley-Liss; 1994. pp. 51-67.
25. Greenstein SM, Schnecter RS, Louis P, et al. Evidence that zero antigen matched, cyclosporine treated renal transplant recipients have graft survival equal to that of matched recipients. Transplantation 1990; 49:332-336.
26. Kerman RH, Kimball PM, Lindholm A, et al. Influence of HLA matching on rejections and short and long term primary cadaveric allograft survival. Transplantation 1993; 56:1242-1247.
27. Terasaki PI, Cecka JM, Gjerston DW, Cho YW. Spousal and other living renal donor transplants. In: Terasaki PI, Cecka JM, editors. Clinical Transplants. 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1997. pp. 269-283.
28. Shoskes DA, Halloran PF. Ischemia injury induces altered MHC gene expression in kidney by an interferon-gamma-dependent pathway. Transplant Proc 1991; 23:599-601.
29. nd International Convocation Immunology 1970; 250-261.
30. Terasaki PI, Kreisler M, Mickey RM. Presensitization and kidney transplant failures. Postgrad Med J 1971; 47:89-100.
31. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280:735-739.
32. Terasaki PI, Bernoco D, Park MS, et al. Microdroplet testing for HLA A, B, C and D antigens. Am J Clin Pathol 1978; 69:103-120.
33. Gebel HG, Bray RA, Nickerson P. Pretransplant assessment of donor-reactive HLA specific antibodies in renal transplantation: contradictions vs risk. Am J Transplant 2003; 3:1489-1500.
34. Kerman RH, Kimball PM, Van Buren CT, et al. AHG and DTE/AHG procedures identify crossmatch appropriate donor recipient pairings which result in improved graft survival. Transplantation 1991; 51:316-320.
35. Kerman RH, Van Buren CT, Lewis RM, et al. Improved graft survival for flow cytometry and antihuman globulin negative retransplant recipients. Transplantation 1990; 49:52-56.
36. Kerman RS, Susskind B, Buyse I, et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation. Transplantation 1999; 68:1855-1858.
37. Cho YW, Cecka JM. Crossmatch tests: an analysis of UNOS data from 1991-2000. In: Terasaki PI, editor. Clinical transplants. Los Angeles: UCLA Immunogenetics Center; 2001. pp. 237-246.
38. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplanttion 2000; 69:319-326.
39. Terasaki PI, Ozawa M. Predicting graft failure by HLA antibodies: a prospective trial. Amer J Transplant 2004; 4:438-443.
40. Kao KJ, Scornik JC, Small SJ. Enzyme linked immunoassay for anti-HLA antibodies: an alternative to panel studies by lymphocytoxicity. Transplantation 1993; 55:192-196.
41. Zachary AA, Griffin J, Lucas DP, et al. Evaluation of HLA antibodies with the PRA-STAT test. An ELISA test using soluble HLA class I molecules. Transplantation 1995; 60:1600-1606.
42. Kerman RH, Susskind B, Buelow R, et al. Correlation of ELISA detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 1996; 62:201-205.
43. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibody screening with flow cytometry. Human Immunol 1998; 59:313-322.
44. Pei R, Lee J, Chen T, et al. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Human Immunol 1999; 60:1293-1302.
45. Fulton RJ, McDade RL, Smith PL, et al. Multiplex analysis with the FlowMetrix system. Clinical Chem 1997; 43:1749-1756.
46. Rose ML. Role of MHC and non-MHC alloantibodies in graft rejection. Current Opinion in Organ Transplantation 2004; 9:16-22.
47. Moraes JR, Stastny P. A new antigen system expressed in human endothelial cells. J Clin Invest 1977; 60:449-454.
48. Stastny P. Endothelial-monocyte antigens. Transpl Proc 1980; 17:32-34.
49. Paul LC, Baldwin WM, Van Es LA. Vascular endothelial alloantigens in renal transplantation. Transplantation 1985; 40:117-123.
50. Moraes JR, Moraes ME, Luo Y, Stastny P. Alloantibodies against donor epidermis and early kidney transplant rejection. Transplantation 1991; 51:370-371.
51. Ahern AT, Artruc SB, DellaPelle P, et al. Hyperacute rejection of HLA identical renal allografts associated with B lymphocytes and endothelial antibodies. Transplantation 1982; 33:103-107.
52. Joyce S, Flye MW, Mohanakumar T. Characterization of kidney cell specific, non-MHC complex alloantigen using antibodies eluted from rejected human allografts. Transplantation 1988; 46:362-368.
53. Wheeler CH, Collins A, Dunn MJ, et al. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant 1995; 14:S188-S197.
54. Barber LD, Whitelegg A, Madrigal JA, et al. Detecting vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation 2004; 77:1604-1609.
55. Jonker M, Danskine A, Haanstra K, et al. The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppressant dependent. Transplantation 2005; 80:385-393.
56. Carter V, Shenton BK, Jaques B, et al. Vimentin antibodies: A non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 2005; 37:654-657.
57. Bahram S, Bresnahan M, Geraghty DE, Spies TA. Second lineage of mammalian histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994; 91:6259-6264.
58. Bahran S. From MAC to MIC: MHC class I genes come full circle. ASHI Quarterly, Second Quarter 2005; 46-48.
59. Sumitran-Holgersson S, Wilczek HE, Soderstrom K. Identification of the nonclassical HLA molecules MICA as targets for humoral immunity associated with irreversible kidney allografts. Transplantation 2002; 74:268-277.
60. Mizutani K, Terasaki PI, Rosen A, et al. Serial ten year follow-up of HLA and MICA antibody production prior to graft failure. Am J Transplant 2005; 5:2265-2272.